COVID-19: FDA Schedules 5 More Virtual Town Halls Through September
Executive Summary
The US agency has announced another month of webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the novel coronavirus.
You may also be interested in...
US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
COVID-19: CDRH Staff Leaves Door Open For Some LDT Safety Oversight
US FDA staff spoke on HHS’s new laboratory developed test edict, as well as ongoing concerns around new test types and reviewer responsiveness in a recent virtual town hall.
FDA Adds 7 New Tools To Its Regulatory Science Toolbox
The US agency has updated its Catalog of Regulatory Science Tools.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: